Weekly Differences in Cumulative RSV Vaccination Coverage Among Adults 75 and Older and 60-74 Years with High-Risk Conditions Ever Vaccinated with RSV Vaccine, Overall, by Selected Demographics

. Weekly Cumulative RSV Vaccination Coverage and Intent Among Adults 75 Years and Older and 60?74 Years with High Risk Conditions Ever Vaccinated with RSV Vaccine by Demographic Characteristics and Jurisdiction . Weekly estimates of RSV vaccination coverage and intent among adults 75 years and older and 60?74 years with high risk conditions are calculated using data from the National Immunization Survey-Adult COVID Module (NIS-ACM) (https://www.cdc.gov/nis/about/) . In June 2023, the Advisory Committee on Immunization Practices (ACIP) voted to recommend that adults aged ?60 years may receive a single dose of an RSV vaccine, using shared clinical decision-making. In June 2024, the ACIP voted to recommend a single dose of RSV vaccine for all adults 75 years and older and adults 60-74 years who are at increased risk for severe RSV disease. The data below captures ever receiving a dose of an RSV vaccine by adults 60 years and older.?